The presence of undifferentiated CD44+CD24−/low tumor cells is an unfavorable prognostic marker in patients with breast cancer, and the increased proportion of CD44+CD24−/low cells is an indicator of probable metastases in the lymph nodes [7]. Here, CD44 is linked to neoplasm.